O'Brien, John T.
University of Cambridge
52 papers on CoChatORCID 0000-0002-0837-5080
Most cited papers
- Verified
Characteristics of Visual Hallucinations in Parkinson Disease Dementia and Dementia With Lewy Bodies
Mosimann, U. P., Rowan, E. N., Partington, C. E., Collerton, D., Littlewood, E., O'Brien, J. T., Burn, D. J., & McKeith, I. G. (2006) · The American Journal of Geriatric Psychiatry
Hallucinations in medical conditionsParkinson's Disease Mechanisms and Treatments
Cited by 188
- Verified
Determining the minimum clinically important differences for outcomes in the DOMINO trial
Howard, R., Phillips, P., Johnson, T., O'Brien, J., Sheehan, B., Lindesay, J., Bentham, P., Burns, A., Ballard, C., Holmes, C., et al. (2011) · International Journal of Geriatric Psychiatry
Dementia and Cognitive Impairment ResearchStatistical Methods in Clinical Trials
Cited by 185
- Verified
Autopsy validation of 123 I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
Thomas, A. J., Attems, J., Colloby, S. J., O'Brien, J. T., McKeith, I., Walker, R., Lee, L., Burn, D., Lett, D. J., & Walker, Z. (2017) · Neurology
Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments
Cited by 165
- Verified
Depressive Symptoms and Cognitive Decline in Community‐Dwelling Older Adults
Köhler, S., van Boxtel, M. P. J., van Os, J., Thomas, A. J., O'Brien, J. T., Jolles, J., Verhey, F. R. J., & Allardyce, J. (2010) · Journal of the American Geriatrics Society
Dementia and Cognitive Impairment ResearchAging, Health, and Disability
Cited by 152
- Verified
EFNS ‐ ENS / EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease
Schmidt, R., Hofer, E., Bouwman, F. H., Buerger, K., Cordonnier, C., Fladby, T., Galimberti, D., Georges, J., Heneka, M. T., Hort, J., et al. (2015) · European Journal of Neurology
Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases
Cited by 140
- Verified
[ 11 C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy
Passamonti, L., Rodríguez, P. V., Hong, Y. T., Allinson, K. S. J., Bevan-Jones, W. R., Williamson, D., Jones, P. S., Arnold, R., Borchert, R. J., Surendranathan, A., et al. (2018) · Neurology
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 115
- Verified
METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research
METACOHORTS Consortium, Dichgans, M., Wardlaw, J., Smith, E., Zietemann, V., Seshadri, S., Sachdev, P., Biessels, G. J., Fazekas, F., Benavente, O., et al. (2016) · Alzheimer's & Dementia
Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments
Cited by 101
- Verified
Dementia wellbeing and COVID-19: review and expert consensus on current research and knowledge gaps
Liu, K. Y., Howard, R., Banerjee, S., Comas‐Herrera, A., Goddard, J., Knapp, M., Livingston, G., Manthorpe, J., O'Brien, J. T., Paterson, R. W., et al. (2021) · International Journal of Geriatric Psychiatry
Dementia and Cognitive Impairment ResearchCOVID-19 and Mental Health
Cited by 87
- Verified
Neuroinflammation predicts disease progression in progressive supranuclear palsy
Malpetti, M., Passamonti, L., Jones, P. S., Street, D., Rittman, T., Fryer, T. D., Hong, Y. T., Vàsquez Rodriguez, P., Bevan-Jones, W. R., Aigbirhio, F. I., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry
Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 85
- Verified
Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy
Malpetti, M., Passamonti, L., Rittman, T., Jones, P. S., Vázquez Rodríguez, P., Bevan‐Jones, W. R., Hong, Y. T., Fryer, T. D., Aigbirhio, F. I., O'Brien, J. T., et al. (2020) · Annals of Neurology
Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 83
- Verified
A study of wrist-worn activity measurement as a potential real-world biomarker for late-life depression
O'Brien, J. T., Gallagher, P., Stow, D., Hammerla, N., Ploetz, T., Firbank, M., Ladha, C., Ladha, K., Jackson, D., McNaney, R., et al. (2017) · Psychological Medicine
Physical Activity and HealthContext-Aware Activity Recognition Systems
Cited by 76
- Verified
In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer’s disease
Low, A., Mak, E., Malpetti, M., Passamonti, L., Nicastro, N., Stefaniak, J. D., Savulich, G., Chouliaras, L., Su, L., Rowe, J. B., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry
Neuroinflammation and Neurodegeneration MechanismsNeurological Disease Mechanisms and Treatments
Cited by 70
- Verified
Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer's disease, and dementia with Lewy bodies
Mak, E., Gabel, S., Su, L., Williams, G. B., Arnold, R., Passamonti, L., Vazquez Rodríguez, P., Surendranathan, A., Bevan-Jones, W. R., Rowe, J. B., et al. (2017) · International Psychogeriatrics
Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and Applications
Cited by 66
- Verified
Vascular factors and depression
Teper, E., & O'Brien, J. T. (2008) · International Journal of Geriatric Psychiatry
Tryptophan and brain disordersCardiac Health and Mental Health
Cited by 55
- Verified
Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies
Donaghy, P. C., Firbank, M. J., Thomas, A. J., Lloyd, J., Petrides, G., Barnett, N., Olsen, K., & O'Brien, J. T. (2018) · Movement Disorders
Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments
Cited by 52
- Verified
Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies
Mak, E., Su, L., Williams, G. B., Watson, R., Firbank, M., Blamire, A. M., & O'Brien, J. T. (2015) · NeuroImage: Clinical
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 51
- Verified
CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-Dementia study
Low, A., Prats-Sedano, M. A., Stefaniak, J. D., McKiernan, E. F., Carter, S. F., Douvani, M.-E., Mak, E., Su, L., Stupart, O., Muniz, G., et al. (2022) · Journal of Neurology, Neurosurgery & Psychiatry
Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research
Cited by 44
- Verified
[18F]AV‐1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation
Bevan Jones, W. R., Cope, T. E., Passamonti, L., Fryer, T. D., Hong, Y. T., Aigbirhio, F., Kril, J. J., Forrest, S. L., Allinson, K., Coles, J. P., et al. (2016) · Annals of Clinical and Translational Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 44
- Verified
In vivo PET imaging of neuroinflammation in familial frontotemporal dementia
Malpetti, M., Rittman, T., Jones, P. S., Cope, T. E., Passamonti, L., Bevan-Jones, W. R., Patterson, K., Fryer, T. D., Hong, Y. T., Aigbirhio, F. I., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 43
- Verified
Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia
Burton, E. J., Mukaetova-Ladinska, E. B., Perry, R. H., Jaros, E., Barber, R., & O'Brien, J. T. (2012) · Neurobiology of Aging
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 43
- Verified
Accuracy of dopaminergic imaging as a biomarker for mild cognitive impairment with Lewy bodies
Roberts, G., Donaghy, P. C., Lloyd, J., Durcan, R., Petrides, G., Colloby, S. J., Lawley, S., Ciafone, J., Hamilton, C. A., Firbank, M., et al. (2021) · The British Journal of Psychiatry
Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments
Cited by 41
- Verified
In vivo evidence for pre‐symptomatic neuroinflammation in a MAPT mutation carrier
Bevan‐Jones, W. R., Cope, T. E., Jones, P. S., Passamonti, L., Hong, Y. T., Fryer, T., Arnold, R., Coles, J. P., Aigbirhio, F. I., O'Brien, J. T., et al. (2019) · Annals of Clinical and Translational Neurology
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 36
- Verified
The incidence of Parkinson's disease in the North-East of England
Duncan, G. W., Khoo, T. K., Coleman, S. Y., Brayne, C., Yarnall, A. J., O'Brien, J. T., Barker, R. A., & Burn, D. J. (2014) · Age and Ageing
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 32
- Verified
Amyloid Imaging and Longitudinal Clinical Progression in Dementia With Lewy Bodies
Donaghy, P. C., Firbank, M. J., Thomas, A. J., Lloyd, J., Petrides, G., Barnett, N., Olsen, K., & O'Brien, J. T. (2020) · The American Journal of Geriatric Psychiatry
Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments
Cited by 31
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free